Snap-on (SNA) CEO Pinchuk exercises 33,750 options and sells stock under 10b5-1 plan
Rhea-AI Filing Summary
Snap-on Inc. insider activity: On 12/02/2025, Chairman, President and CEO Nicholas T. Pinchuk exercised a stock option for 33,750 shares of Snap-on common stock at an exercise price of $138.03 per share and acquired the shares. On the same date, he sold multiple blocks of common stock, including 1,928 shares at a weighted average price of $336.1858, 2,144 shares at $337.2043, 1,760 shares at $338.0581, 7,060 shares at $339.4696, 9,277 shares at $340.071, and 438 shares at $341.533, pursuant to a Rule 10b5-1 trading plan adopted on October 24, 2024.
After these transactions, he beneficially owned 826,363.802 shares directly and 862.228 shares indirectly through a 401(k) plan, along with various outstanding stock options, restricted stock units, performance units and deferred stock units tied to Snap-on common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 33,750 | $0.00 | -- |
| Exercise | Common Stock | 33,750 | $138.03 | $4.66M |
| Sale | Common Stock | 1,928 | $336.1858 | $648K |
| Sale | Common Stock | 2,144 | $337.2043 | $723K |
| Sale | Common Stock | 1,760 | $338.0581 | $595K |
| Sale | Common Stock | 7,060 | $339.4696 | $2.40M |
| Sale | Common Stock | 9,277 | $340.071 | $3.15M |
| Sale | Common Stock | 438 | $341.533 | $150K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Deferred Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024. Includes 1.5127 shares acquired under a dividend reinvestment plan. This transaction was executed in multiple trades at prices ranging from $335.71 to $336.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. his transaction was executed in multiple trades at prices ranging from $336.74 to $337.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $337.78 to $338.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $338.78 to $339.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $339.78 to $340.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $341.48 to $341.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This information is based on a plan statement dated September 30, 2025. Option fully vested. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. 1 for 1. The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
FAQ
What insider transaction did Snap-on (SNA) report for 12/02/2025?
Snap-on reported that its Chairman, President and CEO Nicholas T. Pinchuk exercised a stock option for 33,750 shares of common stock at an exercise price of $138.03 per share on 12/02/2025, and sold multiple blocks of shares on the same date.
Was the Snap-on CEO’s stock sale done under a Rule 10b5-1 plan?
Yes. The filing states that the option exercise and related sales were carried out pursuant to a Rule 10b5-1 Plan adopted on October 24, 2024, and that a portion of the underlying shares was sold to cover the exercise price and estimated tax liability.
What derivative securities tied to Snap-on (SNA) does the CEO hold after the Form 4?
The CEO holds multiple stock options with different exercise prices and expiration dates, as well as restricted stock units, performance units (with target amounts that may vest based on 2023–2025, 2024–2026, and 2025–2027 performance goals), and deferred stock units, all settled on a 1-for-1 basis in Snap-on common stock.
Why were multiple price ranges disclosed for some Snap-on (SNA) stock sales?
For several sales, the filing notes they were executed in multiple trades within price ranges (for example, from $335.71 to $336.70), and the reported price is a weighted average sale price. The reporting person undertakes to provide full trade details upon request.